In recent weeks, the European market has shown signs of steady economic growth and benefited from looser monetary policy, as evidenced by a 1.60% rise in the pan-European STOXX Europe 600 Index. In this environment, companies with strong insider ownership can be particularly attractive to investors, as such ownership often signals confidence in the company’s future prospects and aligns management’s interests with those of shareholders.
Name
Insider Ownership
Earnings Growth
Warimpex Finanz- und Beteiligungs (WBAG:WXF)
25.9%
100.6%
S.M.A.I.O (ENXTPA:ALSMA)
16.1%
72.8%
Skolon (OM:SKOLON)
32.3%
126.5%
MilDef Group (OM:MILDEF)
13.7%
83%
Magnora (OB:MGN)
10.4%
75.1%
KebNi (OM:KEBNI B)
36.3%
61.2%
DNO (OB:DNO)
13.5%
97.5%
CTT Systems (OM:CTT)
17.5%
52%
Circus (XTRA:CA1)
24.1%
66.1%
Bonesupport Holding (OM:BONEX)
10.4%
49.6%
Let’s uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Plejd AB (publ) is a technology company that develops products and services for smart lighting control across several countries including Sweden, Norway, Finland, the Netherlands, and Germany, with a market cap of €8.15 billion.
Operations: The company’s revenue is primarily derived from its Electronic Security Devices segment, which generated approximately 978.99 million SEK.
Insider Ownership: 39.1%
Plejd demonstrates strong growth potential, with earnings forecast to grow significantly at 31.9% annually, outpacing the German market. Despite significant insider selling recently, the company reported impressive financial results for Q3 2025, with net income rising to SEK 35.24 million from SEK 20.32 million year-over-year and revenue increasing substantially. This growth trajectory indicates robust performance amid high insider ownership, highlighting Plejd’s position in the European growth landscape despite recent insider activity concerns.
DB:3CA Ownership Breakdown as at Dec 2025
Simply Wall St Growth Rating: ★★★★★☆
Overview: Bittium Oyj specializes in communications and connectivity solutions, healthcare technology products and services, as well as biosignal measuring and monitoring across Finland, Germany, and the United States, with a market cap of €946.50 million.
Operations: The company’s revenue is derived from segments including Medical (€29.00 million), Defense & Security (€55.50 million), and Engineering Services (€14.72 million).